Dedi Gilad is an Israeli dad who had a problem common among many parents. Every time one of his kids got sick, he ended up waiting for hours to make and appointment and see the doctor in person.
So the entrepreneur had an idea. Instead of taking the sick kid to the doctor, he found a way to bring the doctor right to the child’s home.
While teleconsultations have existed for a while, Gilad and his team understood that the doctor needed to be able to examine the child to make the correct diagnosis, something that just couldn’t be done in a Skype-type format.
So together with fellow entrepreneur Ofar Tzadik, Gilad spent three years developing a tool that would allow parents to be the doctor’s hands and perform basic examinations on their child that result in a high quality information a doctor could use to get the right diagnosis.
Dubbed Tytocare, the home kit includes a user-friendly device that incorporates a stethoscope, otoscope and a camera.
Users are also guided through the process to make certain the doctor receives accurate results.
Once the test is performed, the information is sent to the doctor, who can then review it and make a diagnosis.
Parents can also choose to consult with a doctor in real-time, who can guide the parent through the procedure and help identify the illness.
According to Ophir Lotan, a vice-president for Tytocare, the need for such technology is especially strong in the United States, where healthcare costs are skyrocketing.
“There is a strong need for lowering the load and cost as well as improving accessibility to healthcare services even from the comfort of consumers’ homes,” Lotan told ISRAEL21c in a recent interview.
Already Walgreens is interested in the product and Lotan said the goal is to keep the price low so American consumers can afford it with or without help from their insurance companies.
It “will be affordable for a regular consumer to buy and may be subsidized in the future by insurers or employers for certain populations,” Lotan said about the product, which is current still in the pilot phase.